Dive Brief: Adicet Bio on Thursday reported updated results from an early-stage study testing a blood cancer treatment that harnesses gamma delta T cells, an …

Dive Brief: Bayer plans stop developing cancer cell therapies with Atara Biotherapeutics, informing the California biotech company that it will terminate a research collaboration deal …

Stem cell transplants can effectively cure a wide range of diseases, from blood cancers to rare genetic disorders. They’ve been used for decades and are …

Dive Brief: Novartis will manufacture an experimental cancer cell therapy for the small Philadelphia-based Carisma Therapeutics in a deal that marks another early step in …

Biotechnology stocks ended the first day of the J.P. Morgan Healthcare Conference in the green, but only barely. By Monday afternoon, a closely followed index of …

The Food and Drug Administration has cleared Allogene Therapeutics to resume testing its cancer cell therapies after determining the company’s technology wasn’t to blame for …

Takeda, which has made cell and gene therapy a research focus, is turning to partnerships and acquisitions to help fill out its pipeline. In addition …

The conference is the world’s largest stem cell meeting and will attract more than 2,500 delegates from 60 countries, delivering around $13 million in economic …

Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to establish Celonic`s new …

Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies and start-up specialist firms …

New vessel for ambr® 250 ht system will enable cost-effective, scalable process development of vaccines in cell culture Premieres at the BPI European Summit in …